Morphine and Efinaconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Morphine and Efinaconazole. Common interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people who take Morphine and Efinaconazole have. It is created by eHealthMe based on reports of 55 people who take Morphine and Efinaconazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

55 people who take Morphine and Efinaconazole together, and have interactions are studied.


What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 156,697 Morphine users for its effectiveness, alternative drugs and more.

What is Efinaconazole?

Efinaconazole has active ingredients of efinaconazole. eHealthMe is studying from 136 Efinaconazole users for its effectiveness, alternative drugs and more.

Number of Morphine and Efinaconazole reports submitted per year:

Morphine and Efinaconazole drug interactions.

Common Morphine and Efinaconazole drug interactions by gender *:

female:

  1. Drug ineffective
  2. Abdominal pain upper
  3. Oedema peripheral
  4. Pleural effusion
  5. Tremor
  6. Upper respiratory tract infection
  7. Pneumonia
  8. Asthenia
  9. Blood calcium increased
  10. Blood creatinine increased

male:

n/a

Common Morphine and Efinaconazole drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Behcet's syndrome
  2. Epstein-barr virus infection
  3. General physical health deterioration
  4. Lymphoma
  5. Lymphoproliferative disorder
  6. Nausea
  7. Pneumonia
  8. Respiratory disorder
  9. Skin mass

60+:

  1. Drug ineffective
  2. Abdominal pain upper
  3. Oedema peripheral
  4. Pleural effusion
  5. Tremor
  6. Upper respiratory tract infection
  7. Asthenia
  8. Blood calcium increased
  9. Blood creatinine increased
  10. Bronchopulmonary aspergillosis allergic

Common conditions people have *:

  1. Asthma: 48 people, 87.27%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine and Efinaconazole?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Morphine and Efinaconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Morphine side effects:

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Morphine interactions:

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and efinaconazole (the active ingredients of Morphine and Efinaconazole, respectively), and Morphine and Efinaconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Morphine and Efinaconazole.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: